Semaglutide is well tolerated without threat of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse consequences. A substantial inhabitants afflicted with COVID-19 infection ended up diabetic; as a result utilization of semaglutide in diabetic issues along with CV people could be greatly supportive in maintaining wellbeing care system through this https://jeremyf947zhp0.answerblogs.com/profile